Fact.MR

Drug Discovery Services Market Forecast to 2023: Driven by Industry Major Players, Dynamics, Future Opportunities, Revenue, Growth

Fact.MR has announced the addition of the “ Drug Discovery Services Market Forecast, Trend Analysis & Competition Tracking - Global Market insights 2018 to 2028"report to their offering.

 

Pune, Maharashtra -- (SBWIRE) -- 02/21/2019 -- According to a study by Fact.MR, the global market for drug discovery services market is likely to experience strong growth. By 2026 end, the global market for drug discovery services is also estimated to bring in US$ 16,800.1 million revenue. Advancements in the drug discovery technologies are leading to the better drug discovery services. Some of the upcoming trends in the market in terms of drug discovery technology are regulatory initiatives towards pharmacogenomics technology, combinatorial chemistry technology, etc. there has also been an increase in the adoption of label-free techniques.

Increase in the research and development activities and expenditure, leading pharmaceutical companies moving towards outsourcing are some of the factors resulting in the growth of drug discovery services. Introduction of advanced technology in the drug discovery process is also the major driver in the market growth. However, stringent regulations in some regions on drug discovery services, high cost involved in the discovery of drug and development and usage of animals in testing are hampering the market growth.

Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=375

Competition Tracking

The report also profiles companies that are expected to remain active in the expansion of global drug discovery services marketthrough 2026, which include Syngene, Wuxi Apptec, Aurigene Discovery Technologies, Genscript Biotech Corporation, Covance, Jubilant Biosys, Pharmaceutical Product Development, LLC. (Ppd), Evotec, Charles River Laboratories International, Albany Molecular Research, Inc. (AMRI), GE Healthcare, Merck Millipore, and Thermo Fisher Scientific, Inc.

Hit-To-Lead Identification to Gain Maximum Traction

Compared to the various processes in the drug discovery services, Hit-To-Lead identification is anticipated to gain maximum traction. Hit-To-Lead identification is likely to exceed US$ 6,900 million revenue towards 2026 end. Increasing research based on the High-Throughput Screening (HTS) is the main factor driving the use of hit-to-lead identification process.

Medicinal Chemistry to be the Largest Type of Drug Discovery Services

Medicinal chemistry is projected to emerge as the largest type in the drug discovery services market. Medicinal chemistry is estimated to bring in close to US$ 6,100 million revenue. There has been an increase in the outsourcing by pharmaceutical companies, this is emerging as the driving factor. Many drug discovery services providers based in Asia are increasing their foothold in North America and Europe.

Browse Full Report @ https://www.factmr.com/report/375/drug-discovery-services-market

Small Molecules to Witness Highest Growth in Terms of Revenue

Compared to biologics, small molecules are estimated to account for the highest share in terms of revenue. By 2026 end, small molecules are estimated to exceed US$ 10,800 million revenue. Small molecules are gaining traction as they are easy to characterize, simple and well defined. Also, small molecules can easily enter cells, and can cause cancer cells to die.

Oncology to Hold Largest Revenue Share in the Therapeutic Area

By therapeutic area, oncology is likely to emerge as the largest segment throughout the forecast period. Towards 2026 end, oncology is estimated to exceed US$ 6,900 million revenue. Increasing number of people suffering from cancer is resulting in the high demand for cancer therapies. Hence, oncology is anticipated to experience a significant growth in the coming years.

Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=375

Table of Contents Covered in the report are:

1. Global Economic Outlook

2. Global Drug Discovery Services Market - Executive Summary

3. Global Drug Discovery Services Market Overview
3.1. Introduction
3.1.1. Global Drug Discovery Services Market Taxonomy
3.1.2. Global Drug Discovery Services Market Definition
3.2. Global Drug Discovery Services Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Drug Discovery Services Market Y-o-Y Growth
3.3. Global Drug Discovery Services Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. PESTL Analysis
3.7. Product Life Cycle Analysis
3.8. Drug Discovery & Development Process
3.9. Roadmap to Optimize Regulatory and Commercial Success
3.10. Evolution of R&D Drug Discovery Outsourcing
3.11. Service Provider List
3.12. Key Participants Market Presence (Intensity Map) By Region

4. Global Drug Discovery Services Market Analysis and Forecast 2012-2026
4.1. Global Drug Discovery Services Market Size and Forecast By Process , 2012-2026
4.1.1. Target Selection Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Target Validation Market Size and Forecast, 2012-2026
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.1.3. Hit-To-Lead Identification Market Size and Forecast, 2012-2026
4.1.3.1. Revenue (US$ Mn) Comparison, By Region
4.1.3.2. Market Share Comparison, By Region
4.1.3.3. Y-o-Y growth Comparison, By Region
4.1.4. Lead Optimization Market Size and Forecast, 2012-2026
4.1.4.1. Revenue (US$ Mn) Comparison, By Region
4.1.4.2. Market Share Comparison, By Region
4.1.4.3. Y-o-Y growth Comparison, By Region
4.1.5. Candidate Validation Market Size and Forecast, 2012-2026
4.1.5.1. Revenue (US$ Mn) Comparison, By Region
4.1.5.2. Market Share Comparison, By Region
4.1.5.3. Y-o-Y growth Comparison, By Region
4.2. Global Drug Discovery Services Market Size and Forecast By Type, 2012-2026
4.2.1. Medicinal Chemistry Market Size and Forecast, 2012-2026
4.2.1.1. Revenue (US$ Mn) Comparison, By Region
4.2.1.2. Market Share Comparison, By Region
4.2.1.3. Y-o-Y growth Comparison, By Region
4.2.2. Biology Services Market Size and Forecast, 2012-2026
4.2.2.1. Revenue (US$ Mn) Comparison, By Region
4.2.2.2. Market Share Comparison, By Region
4.2.2.3. Y-o-Y growth Comparison, By Region
4.2.3. Drug Metabolism and Pharmacokinetics Market Size and Forecast, 2012-2026
4.2.3.1. Revenue (US$ Mn) Comparison, By Region
4.2.3.2. Market Share Comparison, By Region
4.2.3.3. Y-o-Y growth Comparison, By Region
4.3. Global Drug Discovery Services Market Size and Forecast By Drug Type, 2012-2026
4.3.1. Small Molecules Market Size and Forecast, 2012-2026
4.3.1.1. Revenue (US$ Mn) Comparison, By Region
4.3.1.2. Market Share Comparison, By Region
4.3.1.3. Y-o-Y growth Comparison, By Region
4.3.2. Biologics Market Size and Forecast, 2012-2026
4.3.2.1. Revenue (US$ Mn) Comparison, By Region
4.3.2.2. Market Share Comparison, By Region
4.3.2.3. Y-o-Y growth Comparison, By Region
4.4. Global Drug Discovery Services Market Size and Forecast By Therapeutic Area, 2012-2026
4.4.1. Oncology Market Size and Forecast, 2012-2026
4.4.1.1. Revenue (US$ Mn) Comparison, By Region
4.4.1.2. Market Share Comparison, By Region
4.4.1.3. Y-o-Y growth Comparison, By Region
4.4.2. Neurology Market Size and Forecast, 2012-2026
4.4.2.1. Revenue (US$ Mn) Comparison, By Region
4.4.2.2. Market Share Comparison, By Region
4.4.2.3. Y-o-Y growth Comparison, By Region
4.4.3. Respiratory Diseases Market Size and Forecast, 2012-2026
4.4.3.1. Revenue (US$ Mn) Comparison, By Region
4.4.3.2. Market Share Comparison, By Region
4.4.3.3. Y-o-Y growth Comparison, By Region
4.4.4. Respiratory Diseases Market Size and Forecast, 2012-2026
4.4.4.1. Revenue (US$ Mn) Comparison, By Region
4.4.4.2. Market Share Comparison, By Region
4.4.4.3. Y-o-Y growth Comparison, By Region
4.4.5. Diabetes Market Size and Forecast, 2012-2026
4.4.5.1. Revenue (US$ Mn) Comparison, By Region
4.4.5.2. Market Share Comparison, By Region
4.4.5.3. Y-o-Y growth Comparison, By Region
4.4.6. Other Therapeutic Areas Market Size and Forecast, 2012-2026
4.4.6.1. Revenue (US$ Mn) Comparison, By Region
4.4.6.2. Market Share Comparison, By Region
4.4.6.3. Y-o-Y growth Comparison, By Region

5. North America Drug Discovery Services Market Size and Forecast, 2012-2026
5.1. North America Outlook
5.2. North America Parent Market Outlook
5.3. North America Target Market Outlook
5.4. Revenue (US$ Mn) Comparison, By Country
5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Process
5.6. Revenue (US$ Mn) Comparison, By Type
5.7. Revenue (US$ Mn) Comparison, By Drug Type
5.8. Revenue (US$ Mn) Comparison, By Therapeutic Area

6. Latin America Drug Discovery Services Market Size and Forecast, 2012-2026
6.1. Latin America Outlook
6.2. Latin America Parent Market Outlook
6.3. Latin America Target Market Outlook
6.4. Revenue (US$ Mn) Comparison, By Country
6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Process
6.6. Revenue (US$ Mn) Comparison, By Type
6.7. Revenue (US$ Mn) Comparison, By Drug Type
6.8. Revenue (US$ Mn) Comparison, By Therapeutic Area

And Continue...

Tables and Figure Covered in the report are:

TABLE 1 Global Drug Discovery Services Market Value (US$ Mn), 2012-2017
TABLE 2 Global Drug Discovery Services Market Value (US$ Mn), 2018-2026
TABLE 3 Global Drug Discovery Services Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global Target Selection Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global Target Selection Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global Target Selection Segment Market Share, By Region 2012-2017
TABLE 7 Global Target Selection Segment Market Share, By Region 2018-2026
TABLE 8 Global Target Selection Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Target Validation Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Target Validation Segment Value (US$ Mn), By Region 2018-2026

And Continue...

FIG. 1 Global Drug Discovery Services Market Value (US$ Mn), 2012-2017
FIG. 2 Global Drug Discovery Services Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3 Global Drug Discovery Services Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4 Global Target Selection Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5 Global Target Selection Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6 Global Target Selection Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7 Global Target Validation Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8 Global Target Validation Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9 Global Target Validation Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10 Global Hit-To-Lead Identification Segment Market Value (US$ Mn) By Region, 2012-2017

And Continue....

About Fact.MR
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

Web: https://www.factmr.com/
Read Industry News at - https://theswisstimes.com